CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Open-market sale EVP and General Counsel sold 10,000 shares at $85.00 ($850,000)
- 4 Open-market sale President & CEO sold 30,000 shares at $82.63 ($2,478,900)
- 4 Open-market sale Director sold 5,000 shares at $86.57 ($432,850)
- 4 Open-market sale EVP and General Counsel sold 12,370 shares at an average $88.43 ($1,093,884)
- 4 Open-market sale CFO & Executive Vice President sold 14,378 shares at an average $88.40 ($1,271,073)
- 4 Open-market sale Director sold 34,750 shares at an average $85.37 ($2,966,736)
- 4 Open-market sale President & CEO sold 40,000 shares at $85.35 ($3,414,000)
- 4 Open-market sale SVP, Controller and PAO sold 2,638 shares at $91.00 ($240,058)
- 4 Open-market sale Director sold 6,181 shares at $90.00 ($556,290)
- 4 Shares withheld for taxes EVP & Chief Commercial Officer gave up 260 shares (to pay taxes)
- 4 Open-market sale Director sold 5,000 shares at $85.00 ($425,000)
- 4 Open-market sale SVP, Controller and PAO sold 2,611 shares at $81.00 ($211,491)
- 4 Grant or award Director acquired 2,550 shares (grant or award)
- 4 Grant or award Director acquired 2,550 shares (grant or award)
- 4 Grant or award Director acquired 2,550 shares (grant or award)
- 4 Grant or award Director acquired 2,550 shares (grant or award)
- 4 Grant or award Director acquired 2,550 shares (grant or award)
- 4 Grant or award Director acquired 2,550 shares (grant or award)
- 4 Grant or award Director acquired 2,550 shares (grant or award)
- 4 Grant or award Director acquired 2,550 shares (grant or award)
Page 13 of 32 · 627 filings